2017. Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s127. DOI:https://doi.org/10.25251/skin.1.supp.126.